Clinical Report: Timely Surgical Treatment of Epilepsy Associated with Mild MOGHE
Overview
This case study highlights the importance of early surgical intervention in a 2-year-old boy with MOGHE-associated epilepsy, who experienced significant neurodevelopmental regression despite pharmacotherapy. The findings suggest that timely surgical treatment may prevent further disease progression and improve rehabilitation outcomes.
Background
Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) is a newly recognized histopathological entity linked to drug-resistant epilepsy, particularly in early childhood. The conventional approaches to identify the epileptogenic zone often fail, complicating management and treatment decisions. Early surgical intervention may be critical in preventing irreversible neurological damage in affected children.
Data Highlights
No numerical data or trial data available in the article.
Key Findings
MOGHE is classified as a special subtype of focal cortical dysplasia by the ILAE.
Children with MOGHE often present with early-onset epileptic spasms and significant neurodevelopmental regression.
Conventional imaging techniques, including MRI and PET, may not reveal clear structural abnormalities in MOGHE.
Active early surgical treatment is recommended for children with MOGHE to mitigate disease progression.
Postoperative seizure freedom is crucial for improving developmental outcomes in infants.
Clinical Implications
Clinicians should consider early surgical evaluation for children with MOGHE-associated epilepsy, especially when there is evidence of neurodevelopmental regression. Timely intervention may enhance rehabilitation prospects and prevent further cognitive decline.
Conclusion
This case underscores the necessity of reevaluating surgical timing in pediatric epilepsy cases associated with MOGHE to optimize patient outcomes. Early surgical intervention may be vital in preventing irreversible developmental damage.
